A question of method: The ethics of managing conflicts of interest

EMBO Reports

Volumn 9, Issue 2, 2008, Pages 119-123

  Hurst, Samia A ^a   Mauron, Alex ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; ETHICAL DECISION MAKING; FUNDING; HEALTH HAZARD; MEDICAL RESEARCH; ORGANIZATIONAL STRUCTURE; PASSIVE SMOKING; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROFESSIONALISM; RESEARCH ETHICS; REVIEW; SCIENTIST; SMOKING CESSATION; SYSTEMATIC ERROR; TOBACCO INDUSTRY;

ANIMALS; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; ETHICS, MEDICAL; HUMANS; TRUST;

EID: 38949159154     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.2008.4     Document Type: Review

References (32)

1. Anon (2006) Editorial note. Eur J Public Health 16: 233
2. Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289: 454-465
3. Brennan TA et al (2006) Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA 295: 429-433
4. Cech TR, Leonard JS (2001) Science and business. Conflicts of interest - moving beyond disclosure: Science 291: 989
5. Check E (2004) Ethics accusations spark rapid reaction from NIH chief. Nature 427: 187
6. Cohen JE (2001) Universities and tobacco money. BMJ 323: 1-2
7. Collier J (2006) The price of independence. BMJ 332: 1447-1449
8. Dana J, Loewenstein G (2003) A social science perspective on gifts to physicians from industry. JAMA 290: 252-255
9. Diethelm PA, Rielle JC, McKee M (2005) The whole truth and nothing but the truth? The research that Philip Morris did not want you to see. Lancet 366: 86-92
10. Drucker J (2004) Beyond conflict of interest: Maybe wrong questions are being asked. BMJ 329: 686
11. Glantz SA (2005) Tobacco money at the University of California. Am J Respir Crit Care Med 171: 1067-1069
12. Johns MM, Barnes M, Florencio PS (2003) Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: Promoting research while maintaining trust. JAMA 289: 741-746
13. Jones RN (2005) Tobacco money and academic freedom. Am J Respir Crit Care Med 172: 933-934
14. Kaiser J (2004) NIH ethics. Staff scientists protest plan to ban outside fees. Science 306: 1276
15. Kaiser J (2005) Conflict of interest. NIH chief clamps down on consulting and stock ownership. Science 307: 824-825
16. Korn D, Ehringhaus SH (2005) NIH conflicts rules are not right for universities. Nature 434: 821
17. LaDou J, Teitelbaum DT, Egilman DS, Frank AL, Kramer SN, Huff J (2007) American College of Occupational and Environmental Medicine (ACOEM): A professional association in service to industry. Int J Occup Environ Health 13: 404-426
18. Leavell NR, Muggli ME, Hurt RD, Repace J (2006) Blowing smoke: British American Tobacco's air filtration scheme. BMJ 332: 227-229
19. MacDonald S, Chrisp T (2005) Acknowledging the purpose of partnership. J Business Ethics 59: 307-317
20. Mauton A, Morabia A, Perneger T, Rochat T (2004) Inquiry Commission Report on Professor Ragnar Rylander. Geneva, Switzerland: University of Geneva
21. Morin K et al (2002) Managing conflicts of interest in the conduct of clinical trials. JAMA 287: 78-84
22. Orlowski JP, Wateska L (1992) The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest 102: 270-273
23. Rose JE (2005) Ethnics of tobacco company funding. Science 308 632
24. Shamasunder B, Bero L (2002) Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA 288: 738-744
25. Spingarn RW, Berlin JA, Strom LB (1996) When pharmaceutical manufacturers employees present grand rounds, what do residents remember? Acad Med 71: 86-88
26. Steinbrook R (2005) Standards of ethics at the National Institutes of Health. N Engl J Med 352: 1290-1292
27. Steinman MA, Shlipak MG, McPhee SJ (2001) Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110: 551-557
28. Stossel TP (2005) Regulating academic-industrial research relationships - solving problems or stifling progress? N Engl J Med 353: 1060-1065
29. Thompson DF (1993) Understanding financial conflicts of interest. N Engl J Med 329: 573-576
30. University of Geneva (2001) L'Université de Genève prehd ses distances avec l'industrie du tabac. Geneva, Switzerland: University of Geneva.
31. Wazana A (2000) Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283: 373-380
32. Wolinsky H (2005) Disease mongering and drug marketing. Does the pharmaceutical industry manufacture diseases as well as drugs? EMBO Rep 6: 612-614